N@N

DANVERS, Mass.--([ BUSINESS WIRE ])--[ Abiomed Inc ]. (NASDAQ: ABMD), a leading provider of [ breakthrough heart support technologies ], today announced its schedule of events at the American College of Cardiology (ACC) 2012 Scientific Sessions in Chicago, IL.

"Mechanical Unloading with Left Ventricular Assist Device after Acute Myocardial Infarction Prevents Adverse Cardiac Remodeling"

At ACC 2012, there will be six Impella poster presentations, five Impella case reviews and four oral Impella presentations. See below for the full schedule of Impella-related presentations at the show.

In addition, Abiomed will be releasing new automated flow control features at this yearas ACC show. The new enhancements further simplify user start-up, operation and patient management, and will be available for hands-on demonstration and simulation at Abiomed ACC booth #9063.

Live Case Updates

The company anticipates live cases utilizing Impella to be broadcast from the participating live case sites in the McCormick Place Convention Center. Further details will be disclosed the day of the scheduled cases, as patient status is relative to change.

ACC 2012 SCHEDULE OF EVENTS

SATURDAY, MARCH 24

8:45 a.m.

• Session Title: Pathogenic and Therapeutic Insights from Experimental Heart Failure Models
  • aMechanical Unloading with Left Ventricular Assist Device after Acute Myocardial Infarction Prevents Adverse Cardiac Remodelinga
    Presenter: Xufeng Wei, M.D.
    
    ACC Oral Contributions: Session 906
    McCormick Place South, S404

9:30 a.m.

• Session Title: Outcomes of Patients Treated with PCI
  • aCost-effectiveness and Quality of Life Improvements: Hemodynamic Support Devices in High Risk Patients Receiving PCIa
    Presenter: Brijeshwar Maini, M.D.
    
    ACC Poster Session: Poster # 241
    McCormick Place South, Hall A

SUNDAY, MARCH 25

11:00 a.m.

• Session Title: Acute Coronary Syndromes: Therapy IV
  • aCost-Effectiveness of Impella Hemodynamic Support in the Emergent Care Patient Groupa
    Presenter: Brijeshwar Maini, M.D.
    
    ACC Poster Session: Poster # 564
    McCormick Place South, Hall A

12:45 p.m.

• Session Title: Multi-Vessel and Hemodynamic Support Case Reviews
  • aEffusive-Constrictive Pericarditisa
    Presenter: David Bartov, M.D.
    
    ACC-i2 Meet the Experts: Session 2310
    McCormick Place South, S102c

MONDAY, MARCH 26

8:15 a.m.

• Session Title: Multi-Disciplinary Management of the Failing Heart: Team Based Evaluation and Therapy of Advanced Heart Disease
  • aCase Presentation 1a
    Presenter: Brian P. O'Neill, M.D.
    
    ACC-i2 Special Session: Session 2121
    McCormick Place South, S102c

8:30 a.m.

• Session Title: Shock in ACS
  • aRole of LV Assist Device in Cardiogenic Shocka
    Presenter: John M. Lasala, M.D.
    
    ACC Symposium Session: Session 676
    McCormick Place South, S401a

9:30 a.m.

• Session Title: Mechanical Circulatory Support: Innovations and Outcomes
  • aFirst Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RPa
    Presenter: Anson Cheung, M.D.
    
    ACC Poster Session: Poster # 11
    McCormick Place South, Hall A

9:30 a.m.

• Session Title: Ventricular Arrhythmias in 2012: From the J-Wave and Early Repolarization to LVADs
  • aRole of Percutaneous Left Ventricular Assist Devices in Unstable Ventricular Arrhythmia Ablationa
    Presenter: Madhu Reddy, M.D.
    
    ACC Poster Session: Poster # 356
    McCormick Place South, Hall A

11:00 a.m.

• Session Title: When PCI Is Not a Slam Dunk
  • aThe PROTECT II Studya
    Presenter: Jeffrey J. Popma, M.D.
    
    ACC Poster Session: Poster # 295
    McCormick Place South, Hall A

11:15 a.m.

• Session Title: Multi-Disciplinary Management of the Failing Heart: Team Based Evaluation and Therapy of Advanced Heart Disease II
  • aCase Presentation 4a
    Presenter: David Bartov, M.D.
    
    ACC-i2 Special Session: Session2122
    McCormick Place South, S102c

12:15 p.m.

• Session Title: Shock and Hemodynamic Support Case Reviews
  • 12:33 p.m. -12:43 p.m.
    aPercutaneous Coronary Intervention With Left Ventricular Support From A 2.5 Impella Via A Left Axillary Chimneya
    Presenter: Syed Tanveer Rab, M.D.
  • 12:51 p.m. - 1:01 p.m.
    aA Case of Acute Septal Rupture Followed by Right Ventricular Free Wall Rupture in a Patient with Takotsubo Cardiomyopathy Managed with Percutaneous Left Ventricular Supporta
    Presenter: Joanne Ilustre, M.D.
  • 1:09 p.m. - 1:19 p.m.
    aPercutaneous Ventricular Support: A 56 Year-Old Man With Acute Fulminant Myocarditisa
    Presenter: Andrew Edward Kott, M.D.
    
    ACC-i2 Meet the Experts: Session 2315
    McCormick Place South, S102

2:45 p.m.

• Session Title: State of the Art STEMI: All You Need to Know
  • aMechanical Support for Treatment of Cardiogenic Shock and Hemodynamic Instabilitya
    Presenter: John M. Lasala, M.D.
    
    ACC-i2 Symposium Session: Session 2638
    McCormick Place South, S106b

3:57 p.m.

• Session Title: ACS: New Insights and Novel Therapies
  • aAdjunctive Therapies to Mitigate Ischemia-Reperfusion Injurya
    Presenter: William W. O'Neill, M.D.
    
    ACC-i2 Symposium Session: Session 2643
    McCormick Place South, S106b

ABOUT ABIOMED

Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Our products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart. For additional information please visit: [ www.abiomed.com ].

FORWARD-LOOKING STATEMENTS

This Release contains forward-looking statements, including statements regarding development of Abiomed's existing and new products, the Company's progress toward commercial growth, and future opportunities. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, anticipated future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, future capital needs and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission, including the Annual Report filed on Form 10-K and most recent Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this Release or to reflect the occurrence of unanticipated events.